Pavet et al., in 2010, reported that DR5-selective TRAIL-mimetic peptides (M1d) have vigorous tumoricidal activity against xenografted colon cancer cells (Pavet et al., 2010). The gene discussed is TNFRSF10B; the disease is malignant colon neoplasm.